Filing Details
- Accession Number:
- 0001209191-16-091089
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2016-01-12 19:00:16
- Reporting Period:
- 2015-12-31
- Filing Date:
- 2016-01-12
- Accepted Time:
- 2016-01-12 19:00:16
- Original Submission Date:
- 2016-01-05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1346830 | Cara Therapeutics Inc. | CARA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1597359 | Dean Slagel | C/O Esperante Nv, Siriusdreef 22 Hoofddorp P7 2132 WT | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2015-12-31 | 12,776 | $17.00 | 1,345,562 | No | 4 | S | Indirect | By Esperante Holding NV |
| Common Stock | Disposition | 2016-01-05 | 31,224 | $17.01 | 1,314,338 | No | 4 | S | Indirect | By Esperante Holding NV |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Esperante Holding NV |
| No | 4 | S | Indirect | By Esperante Holding NV |
Footnotes
- These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by Esperante Holding NV on December 17, 2015 (See Footnote 3 herein).
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.00 - $17.08, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- These shares are owned by Esperante Holding NV. The Reporting Person is a director of the Issuer and the Managing Director of Esperante BV, a wholly-owned subsidiary of Esperante Holding NV. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.00 - $17.14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4.
Billionaire Hedge Funds
